| Why carry out this study? |
| As type 2 diabetes mellitus (T2DM) not only often complicates nonalcoholic fatty liver disease (NAFLD) but also contributes to the progression of the pathogenesis of NAFLD, developing optimal treatment strategies for patients with NAFLD complicated by T2DM is important to prevent the progression of NAFLD. |
| Several treatments for NAFLD have been suggested, but the rate of nonalcoholic steatohepatitis (NASH) resolution has not sufficiently improved. |
| What will be learned from the study? |
| This study may identify a new treatment option for NASH complicated by T2DM. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.